反复着床失败患者的临床病例对照研究

摘要
图/表
参考文献(42)
相关文章 (8)

全文: PDF (379 KB) HTML (46 KB)
输出: BibTeX | EndNote (RIS) 背景资料

文章导读

摘要目的回顾分析在行体外授精胚胎移植(IVF-ET)助孕过程中反复着床失败(RIF)患者的临床资料,旨在发现反复着床失败的高危因素,以期早期识别并降低反复着床失败的发生率。方法选取2015年—2016年诊断为反复着床失败患者196例作为RIF组,并选取与RIF组患者同期行第一次IVF助孕且成功获得妊娠的患者392例作为正常对照组。分析两组患者的基本资料、不孕病因及第一次IVF周期的相关资料。此外,根据患者的年龄将以上统计资料进行年龄的分层分析。结果患者丈夫年龄和子宫内膜异位症是反复着床失败的危险因素,而总2PN率、优质胚胎率及A型内膜则是反复着床失败的保护因素。年龄分层分析显示女方年龄≥35岁组中丈夫年龄、ICSI-2PN率在RIF组和对照组间有统计学差异。30≤年龄<35岁组中无排卵性不孕、男方因素、优质胚胎数、总2PN率、IVF-2PN率、ICSI-2PN率及优质胚胎率在两组间有统计学差异。而年龄<30岁组中雄激素水平、内膜厚度、获卵总数及2PN数在两组间有统计学差异。结论不孕患者的丈夫年龄越大发生反复着床失败的风险越高;合并子宫内膜异位症的不孕患者更容易发生反复着床失败,而受精率高、胚胎质量好及HCG日为A型内膜形态的的患者行IVF助孕的成功率高。此外,应根据患者的年龄进行分层化管理。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	贾婉璐
	王海燕
	乔杰
	刘平
	李蓉
	陈新娜
	王颖

关键词 ：反复着床失败, 高危因素, 2PN率

Abstract：Objective In order to find the risk factors of recurrent implantation failure and to reduce the incidence of recurrent implantation failure by retrospective analysis of the clinical data of the patients with recurrent implantation failure.Methods 196 cases who were diagnosed as recurrent implantation failure during 2015-2016, and 392 patients with successful pregnancy of their first IVF cycle which was preformed at the same month with recurrent implantation failure patients were selected as the control group. The clinical data of the two groups were analyzed, including basic information, the cause of infertility and the first IVF cycle-related information. Besides, according to patients' age, we analyze the clinical data in each group.Results Patients' husband age and endometriosis are risk factors for recurrent implantation failure, while the 2PN rate, the rate of good quality embryo and A pattern of the endometrium are protective factors for recurrent implantation failure. Analysis on Stratification of Age revealed that the age of the husband and ISCI-2PN rate had statistical significance in Group A, and anovulatory infertility, male factors, high quality embryos, total 2PN rate, IVF-2PN rate, ICSI-2PN rate and high quality embryo rate were significantly different in Group B, and there were significant differences in androgen levels, endometrial thickness, total oocytes count and 2PN numbers in Group C.Conclusion The higher the age of the husband, the higher the risk of recurrent implantation failure, and the infertile patients combined with endometriosis are prone to recurrent implantation failure. While the success rate of IVF assisted pregnancy was high in patients with high fertilization rate, good embryo quality and A pattern endometrium. In addition, stratification management according to the patients' age should be used.

Key words： RIF risk factors 2PN rate

收稿日期: 2022-07-15

ZTFLH:	R71
	R17

基金资助:

通讯作者: 王海燕(wangquan1991@sina.com)

引用本文:

贾婉璐, 王海燕, 乔杰, 刘平, 李蓉, 陈新娜, 王颖. 反复着床失败患者的临床病例对照研究[J]. 中国生育健康杂志, 2024, 35(1): 40-47. JIA Wanlu, WANG Haiyan, QIAO Jie, LIU Ping, LI Rong, CHEN Xinna, WANG Ying. Clinical case-control study in patients with recurrent implantation failure. Chinese Journal of Reproductive Health, 2024, 35(1): 40-47.

链接本文:

http://cjrh.bjmu.edu.cn/CN/ 或 http://cjrh.bjmu.edu.cn/CN/Y2024/V35/I1/40

1 Messinis IE,Messini CI,Daponte A,et al.The current situation of infertility services provision in Europe.Eur J Obstet Gynecol Reprod Biol,2016:S0301-2115(16)30952-30956 [pii].
2 Coughlan C,Ledger W,Wang Q,et al.Recurrent implantation failure:definition and management.Reprod Biomed Online,2014,28:14-38.
3 Pirtea P,Scott RT Jr,de Ziegler D,et al.Recurrent implantation failure:how common is it? Curr Opin Obstet Gynecol.2021 ,33:207-212.
4 中国医师协会妇产科医师分会,中华医学会妇产科学分会子宫内膜异位症协作组.子宫内膜异位症诊治指南(第三版).中华妇产科杂志,2021,56:812-824.
5 World Health Organization Scientic Group Report:Recent advances in medically assisted conception.WHO Technical Report Series820.Geneva,WHO,1992.
6 Stewart J A.Stimulated intrauterine insemination is not a natural choice for the treatment of unexplained subfertility.Hu—mall Reprod,2003,18:903-907.
7 中华医学会.临床诊疗指南·辅助生殖技术与精子库分册.北京:人民卫生出版社,2009.
8 World Health Organization.WHO laboratory manual for examination of human semen and semen–cervical mucus interaction.4th ed.Cambridge:Cambridge University Press,1999.
9 谷翊群,陈振文,卢文红,等.世界卫生组织人类精液检查与处理实验手册.北京:人民卫生出版社,2010.
10 乔杰,马彩虹,刘嘉茵,等.辅助生殖促排卵药物治疗专家共识.生殖与避孕,2015,35:211-223.
11 Ugwu HC,Onwuzu S,Agbo JA,et al.Sonographic prediction of successful embryonic implantation in in-vitro fertilization and embryo transfer cycle procedures,using a multi-parameter approach.Radiography (Lond),2022,28:473-479.
12 Zhao J,Zhang Q,Li Y.The effect of endometrial thickness and pattern measured by ultrasonography on pregnancy outcomes during IVF-ET cycles.Reprod Biol Endocrinol,2012,10:100.
13 Zhang HH,Xu PY,Wu J,et al.Dehydroepiandrosterone improves follicular fluid bone morphogenetic protein-15 and accumulated embryo score of infertility patients with diminished ovarian reserve undergoing in vitro fertilization:a randomized controlled trial.J Ovarian Res,2014,7:93.
14 Murugesu S,Kasaven LS,Petrie A,et al.Does advanced paternal age affect outcomes following assisted reproductive technology? A systematic review and meta-analysis.Reprod Biomed Online,2022,45:283-331.
15 Gao J,Yuan R,Yang S,et al.Age-related changes in human conventional semen parameters and sperm chromatin structure assay-defined sperm DNA/chromatin integrity.Reprod Biomed Online,2021,42:973-982.
16 Vogiatzi P,Pouliakis A,Sakellariou M,et al.Male age and progressive sperm motility are critical factors affecting embryological and clinical outcomes in oocyte donor ICSI cycles.Reprod Sci,2022,29:883-895.
17 Lu JC,Jing J,Chen L,et al.Analysis of human sperm DNA fragmentation index (DFI) related factors:a report of 1010 subfertile men in China.Reprod Biol Endocrinol,2018,16:23.
18 Zhang F,Li J,Liang Z,et al.Sperm DNA fragmentation and male fertility:a retrospective study of 5114 men attending a reproductive center.J Assist Reprod Genet,2021,38:1133-1141.
19 Guo LY,Zhou H,Liu M,et al.Male age is more critical to sperm DNA integrity than routine semen parameters in Chinese infertile males.Andrologia,2020,52:e13449.
20 Simon L,Zini A,Dyachenko A,et al.A systematic review and meta-analysis to determine the effect of sperm DNA damage on in vitro fertilization and intracytoplasmic sperm injection outcome.Asian J Androl,2017,19:80-90.
21 Ribas-Maynou J,Yeste M,Becerra-Tomás N,et al.Clinical implications of sperm DNA damage in IVF and ICSI:updated systematic review and meta-analysis.Biol Rev Camb Philos Soc,2021,96:1284-1300.
22 Tomassetti C,D'Hooghe T.Endometriosis and infertility:Insights into the causal link and management strategies.Best Pract Res Clin Obstet Gynaecol,2018,51:25-33.
23 Filip L,Duicǎ F,Prǎdatu A,et al.Endometriosis associated infertility:a critical review and analysis on etiopathogenesis and therapeutic approaches.Medicina (Kaunas),2020,9;56:460.
24 Younes,G,Tulandi,T.Effects of adenomyosis on in vitro fertilization treatment outcomes:A meta-analysis.Fertil Steril,2017,108,483-490.
25 Cozzolino M,Tartaglia S,Pellegrini L,et al.The effect of uterine adenomyosis on IVF outcomes:a systematic review and meta-analysis.Reprod Sci,2022,29:3177-3193.
26 Ferrell K,Rohlfs A,Hansen K,et al.Endometriosis and infertility.S D Med,2020,73:350-355.
27 Muzii L,DI Tucci C,Galati G,et al.Endometriosis-associated infertility:surgery or IVF.Minerva Obstet Gynecol,2021,73:226-232.
28 Franasiak JM,Alecsandru D,Forman EJ,et al.A review of the pathophysiology of recurrent implantation failure.Fertil Steril,2021,116:1436-1448.
29 Bashiri A,Halper KI,Orvieto R.Recurrent implantation failure-update overview on etiology,diagnosis,treatment and future directions.Reprod Biol Endocrinol,2018,16:121.
30 Neri QV,Lee B,Rosenwaks Z,et al.Understanding fertilization through intracytoplasmic sperm injection (ICSI).Cell Calcium,2014,55:24-37.
31 O'Neill CL,Chow S,Rosenwaks Z,et al.Development of ICSI.Reproduction,2018,156:F51-F58.
32 Gatimel N,Parinaud J,Leandri RD.Intracytoplasmic morphologically selected sperm injection (IMSI) does not improve outcome in patients with two successive IVF-ICSI failures.J Assist Reprod Genet,2016,33:349–55.
33 Mangoli E,Khalili MA.The beneficial role of intra cytoplasmic morphologically selected sperm injection (IMSI) in assisted reproduction.J Reprod Infertil,2020,21:3-10.
34 Watson AJ.Oocyte cytoplasmic maturation:a key mediator of oocyte and embryo developmental competence.J Anim Sci,2007,85:E1-3.
35 Xue W,Zhang DD,Zhen JR,et al.Factors contributing to good oocyte competence and utility rates for in vitro fertilization or intracytoplasmic sperm injection in high responders.Chin Med J (Engl),2021,134:1379-1381.
36 Yanagida K,Morozumi K,Katayose H,et al.Successful pregnancy after ICSI with strontium oocyte activation in low rates of fertilization.Reprod Biomed Online,2006,13:801-806.
37 Tavalaee M,Kiani-Esfahani A,Nasr-Esfahani MH.Relationship between potential sperm factors involved in oocyte activation and sperm DNA fragmentation with intra-cytoplasmic sperm injection clinical outcomes.Cell J,2017,18:588-596.
38 Craciunas L,Gallos I,Chu J,et al.Conventional and modern markers of endometrial receptivity:a systematic review and meta-analysis.Hum Reprod Update,2019,25:202-223.
39 Liao S,Wang R,Hu C,et al.Analysis of endometrial thickness patterns and pregnancy outcomes considering 12,991 fresh IVF cycles.BMC Med Inform Decis Mak,2021,21:176.
40 Ocal P,Cift T,Bulut B,et al.Recurrent implantation failure is more frequently seen in female patients with poor prognosis.Int J Fertil Steril,2012,6:71-78.
41 Lebbe M,Woodruff TK.Involvement of androgens in ovarian health and disease.Mol Hum Reprod,2013,19:828-837.
42 Gleicher N,Weghofer A,Barad DH.The role of androgens in follicle maturation and ovulation induction:friend or foe of infertility treatment.Reprod Biol Endocrinol,2011,9:116.